Market narrative
Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.
HOUSTON--(BUSINESS WIRE)--Phillips 66 announced that the board of directors has approved a $10 billion increase to the share repurchase authorization.
Press releases
Industry recognition highlights the company's longstanding commitment to organic agriculture, regenerative practices and sustainable retail operations LAKEWOOD, Colo., July 31, 2026 /PRNewswire/ -- Natural Grocers®, the leading family-operated organic and natural grocery retailer in the U.S., has been named 2026 Sustainability Retailer of the Year by Produce Business, a leading trade publication serving the fresh produce industry.
VANCOUVER, BC / ACCESS Newswire / July 31, 2026 / Faraday Copper Corp. ("Faraday") (TSX:FDY)(OTCQX:CPPKF) is pleased to announce it has filed its management information circular (the "Circular") and related proxy materials (the "Meeting Materials") to Faraday shareholders (the "Shareholders") in connection with the special meeting of Shareholders to be held virtually at 9:00am Pacific Time on August 25, 2026 (the "Meeting"). The Meeting is intended to approve an ordinary resolution (the "Share Issuance Resolution") approving the issuance of Faraday common shares to a wholly owned subsidiary of BHP Group Limited ("BHP") as consideration for the previously announced transaction (the "Transaction") whereby Faraday will acquire from BHP the San Manuel property ("San Manuel"), adjacent to Faraday's Copper Creek project ("Copper Creek"), in Arizona, USA.
Perth, Western Australia--(Newsfile Corp. - July 31, 2026) - Besra Gold Inc (ASX: BEZ) (Besra or the Company) provides the
MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming investor conferences in August 2026.
CALGARY, Alberta, July 31, 2026 (GLOBE NEWSWIRE) -- TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) today reported its financial results for the second quarter ended June 30, 2026.
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it will publish financial results for the second quarter 2026 and provide a business update on Thursday, August 6, 2026. About Precision BioSciences, Inc. Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improvin.
SINGAPORE, July 31, 2026 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced its financial results for the year ended March 31, 2026.
Reports second quarter revenue of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(1.97) Reiterates plan to deliver up to 10% revenue growth in 2026 Improves 2026 GAAP operating expense outlook by approximately $0.2 billion from previous estimate and improves expected 2026 year-end cash balance to $4.7 - 5.2 billion Anticipates potential approval of Moderna's fifth product with the August 5th PDUFA date for mFLUSIVA, the Company's seasonal influenza vaccine candidate Announces that mRNA-1403, Moderna's norovirus vaccine candidate, did not meet statistical criteria for early success at the Phase 3 interim analysis and the Company is preparing to enroll an additional cohort CAMBRIDGE, MA / ACCESS Newswire / July 31, 2026 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2026. "The second quarter marked another period of strong execution for Moderna as we advanced our pipeline and strengthened our financial profile with an improved 2026 operating expense outlook," said Stéphane Bancel, Chief Executive Officer of Moderna.
CALGARY, AB, July 31, 2026 /PRNewswire/ - Enbridge Inc. (Enbridge or the Company) (TSX: ENB) (NYSE: ENB) today reported second quarter 2026 financial results, reaffirmed its 2026 financial guidance and provided a quarterly business update. Highlights (All financial figures are unaudited and in Canadian dollars unless otherwise noted.
CHICAGO, July 31, 2026 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE: TDS) and Array Digital Infrastructure, Inc.(NYSE: AD) will webcast their second quarter operating results conference call on August 7, 2026, at 9:00 a.m. Central Time.
CENTENNIAL, CO / ACCESS Newswire / July 31, 2026 / Nepra Foods Inc. (CSE: NPRA)(FSE: 2P6)(OTCQB: NPRFF) ("Nepra Foods" or the "Company"), a food and beverage company focused on product innovation, manufacturing and consumer wellness products, is pleased to announce that it has filed its audited annual financial statements, management's discussion and analysis ("MD&A"), and related CEO and CFO certifications (collectively, the "Annual Filings") for the fiscal year ended March 31, 2026. The Annual Filings have been filed on SEDAR+ and posted on the Canadian Securities Exchange ("CSE") and OTCQB websites.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / July 31, 2026 / ATHA Energy Corp. ("ATHA" or the "Company") (TSXV:SASK)(OTCQX:SASKF)(FRA:X5U) announces that in accordance with the terms of the US$25,000,000 twelve percent convertible debenture issued to Queen's Road Capital Investment Ltd. ("QRC") on February 5, 2026 (the "Convertible Debenture"), the Company has elected to issue 340,136 common shares in the capital of the Company ("Common Shares") at a deemed price of US$0.735 (C$1.031) to QRC as payment for US$249,999.96 (C$350,349.941) in interest owing on the Convertible Debenture.
New York, New York--(Newsfile Corp. - July 31, 2026) - OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced American Tungsten Corp. (TSXV: TUNG) (OTCQX: TUNGF), a Canadian-based exploration and development company, has qualified to trade on the OTCQX® Best Market. American Tungsten Corp. upgraded to OTCQX from the OTCQB® Venture Market.
Company expects to use a portion of financing proceeds to prepay existing secured indebtedness following five-business-day notice period Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - Bitzero Holdings Inc. (NASDAQ: AIBZ) (CSE: AIBZ.U) (FSE: 000) ("Bitzero" or the "Company"), a provider of sustainable high-performance compute ("HPC") and AI data center infrastructure, announces that it has delivered the required notice under the Company's existing senior secured loan facility with a syndicate of lenders (the "Loan") of the Company's intention to prepay the outstanding obligations under the Loan. The Company expects to complete the prepayment on or about August 6, 2026, following expiry of the applicable five-business-day notice period under the Loan.
Management to host conference call and webcast at 4:30 pm ET on that day BOCA RATON, Fla, July 31, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced t that it will host a conference call on Thursday, August 6th, 2026 at 4:30pm EDT to discuss results for its quarter ended June 30, 2026 and to provide a corporate update. Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call.
WATERTOWN, Mass., July 31, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions, today provided a business update and reported financial results for the second quarter ended June 30, 2026.
BOSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces quantitative PET imaging results from the third patient with Multiple System Atrophy (MSA) in the Phase 2 clinical trial treated with intranasal foralumab to complete dosing.
Company expects to report topline data from Phase 3 LEVEL clinical trial in August 2026 CHAPEL HILL, N.C., July 31, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”) today reported financial results for the quarter ended June 30, 2026 and provided an update on its corporate progress.
BOCA RATON, Fla., July 31, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that on July 30, 2026, it received a research and development cash rebate from Australia of approximately $4.2 million. This rebate is in addition to approximately $0.4 million of rebate from the United Kingdom during June 2026. After adjusting second-quarter operating cash flows to exclude the approximately $0.4 million rebate received during the quarter, the combined rebate proceeds exceeded the Company's net cash used in operating activities during the quarter. The rebates strengthen the Company's balance sheet and extend its cash runway as INmune Bio advances CORDStrom™ (Ebstrocel™) toward regulatory filings.
